Construction of strains.
Standard procedures for the manipulation of plasmid DNA were described before and GFP2, which included restriction sites for AsuII and NotI, respectively. Next, the resulting plasmid pGAP-GFP was further modified by replacing the sequence between the NotI and SalI sites with a 1,355 bp MIG1 DNA (NotI-SalI) amplified by PCR from the genomic DNA of P. pastoris, thus generating a plasmid pGLM1. Finally, the plasmid pGLM1 was transformed by electroporation into wild-type P. pastoris strain GS115. Zeocin resistance transformants were isolated on YPD medium supplemented with 0.1 mg/ml zeocin. The method of construction of the GS115/pGLM2 strain was the same as that used for the GS115/pGLM1 strain. Both of the transformants were used to observe the subcellular localization of strains were crossed and diploid hybrids 4 were selected on YPD medium supplemented with zeocin (0.2 mg/ml) and G418 (1 mg/ml). After sporulation, the Δmig1Δmig2 double-deletion mutant was selected plates. The Mut + strains were selected and named as P. pastoris MF1-GFP. Similarly, a strain which expressing GFP in ∆mig1∆mig2 was constructed and named as Δmig1Δmig2-Mit1-GFP. Then the insulin precursor (IP) plasmid pPIC9K/IP, which was constructed previously 5 , was linearized by PmeI and transformed into P. pastoris MF1. The Mut + transformants which could grow on the maximum concentration of 0.5, 1, 1.5, 2, 3, 4, 5 and 6 mg/mL G418 respectively were screened. Strains with the maximum production of IP in 500-mL baffled shake flask induced by glycerol were selected and designated as P. pastoris MF1-IP.
